View ValuationInventurus Knowledge Solutions 향후 성장Future 기준 점검 4/6Inventurus Knowledge Solutions (는) 각각 연간 17.2% 및 14.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 16.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 24.9% 로 예상됩니다.핵심 정보17.2%이익 성장률16.11%EPS 성장률Healthcare Services 이익 성장32.7%매출 성장률14.6%향후 자기자본이익률24.94%애널리스트 커버리지Good마지막 업데이트09 Jul 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • 11hInventurus Knowledge Solutions Limited Announces Board ChangesInventurus Knowledge Solutions Limited held its Board of Directors meeting on August 5, 2026, and considered and approved the retirement of Mr. Berjis Desai, Non-Executive Chairman and Non-Independent Director (DIN: 00153675), with effect from the conclusion of the ensuing 20th Annual General Meeting (AGM) on September 21, 2026. The Board has designated Mr. Clarence Carleton King II (DIN: 08171208), Independent Director of the Company, as the Non-Executive Chairman and Independent Director of the Company, with effect from the conclusion of the ensuing 20th AGM September 21, 2026, consequent to the retirement of Mr. Berjis Desai as Non- Executive Chairman and Non-Independent Director. Mr. Berjis Desai has expressed his unwillingness to seek re- appointment at the ensuing 20th Annual General Meeting ("AGM") of the Company, consequent to his appointment at Member of National Commission for Minorities, Government of India, New Delhi. Mr. Clarence Carleton King II (Carl) is a senior health care executive with 40 years of diverse experience. His deep expertise in health care financing and delivery allows Carl to understand the health care system holistically from the perspective of numerous participants. On the delivery side, Carl has run hospitals, clinics and ambulatory surgery centers. On the financing side, he has run HMOs, PPOs and other types of managed care plans. Carl has worked for publicly traded, privately held and provider-sponsored companies. Over the course of his career, he ran local, regional and national organizations with profit and loss responsibility ranging from a few million dollars to over nine billion dollars annually. Carl serves on numerous boards. He is a Certified Corporate Director by the National Association of Corporate Directors and the Indian Institute of Corporate Affairs. Carl also serves as an expert witness in health care cases. He is currently chairing an arbitration panel in a large health care dispute resolution case.공고 • Jul 28Inventurus Knowledge Solutions Limited to Report Q1, 2027 Results on Aug 05, 2026Inventurus Knowledge Solutions Limited announced that they will report Q1, 2027 results on Aug 05, 2026Reported Earnings • May 14Full year 2026 earnings: Revenues and EPS in line with analyst expectationsFull year 2026 results: EPS: ₹43.12 (up from ₹29.20 in FY 2025). Revenue: ₹32.1b (up 21% from FY 2025). Net income: ₹7.22b (up 48% from FY 2025). Profit margin: 23% (up from 18% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Healthcare Services industry in Asia.공고 • May 06Inventurus Knowledge Solutions Limited to Report Q4, 2026 Results on May 13, 2026Inventurus Knowledge Solutions Limited announced that they will report Q4, 2026 results on May 13, 2026Valuation Update With 7 Day Price Move • Apr 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,654, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Healthcare Services industry in Asia. Total returns to shareholders of 12% over the past year. Simply Wall St's valuation model estimates the intrinsic value at ₹735 per share.공고 • Apr 17Inventurus Knowledge Solutions Limited Debuts MyCareHub Agentic AI PlatformInventurus Knowledge Solutions Limited announce the groundbreaking launch of MyCareHub™, a proven agentic AI self-orchestrating platform that puts patients first and transforms how they engage with their healthcare journey before, during and after care, at the annual conference of the American Medical Group Association (AMGA) April 15-18. The novel care model, now integrated with Epic and available in the Epic Connection Hub, uses an active, aware and constant multi-agent behavioral algorithm to create a patient engagement operating system that is adaptive, autonomous and patient-first. MyCareHub uses behavioral modeling, longitudinal patient memory, decision intelligence, orchestration logic, safety guardrails and transparent autonomy controls to create a novel patient engagement platform that scores awareness of obligations, ability to meet them and willingness to do so. The channel, cadence and tone of reminders are personalized to drive adherence, ensuring quality care that ultimately lowers total cost of care. IKS Health implemented Recent year-over-year comparison data* from OrthoNY’s MyCareHub platform showed: 4.7% increase in total patient collections; 9.4% increase in patient payments per visit; 8.25% increase in net payments per visit.공고 • Apr 14Inventurus Knowledge Solutions Reportedly in Advanced Negotiations to Acquire TruBridge for $600 MillionInventurus Knowledge Solutions Limited (NSEI:IKS) is in advanced negotiations to acquire Nasdaq-listed TruBridge, Inc. (NasdaqGS:TBRG) in the US for around $600 million, said people aware of the matter. If the deal takes place, this will be the company's largest purchase and will help consolidate its presence in the healthcare solutions and revenue cycle management (RCM) segment, the people said. The transaction is in line with heightened investor interest in the space, which has seen unprecedented consolidation in the past two years. A formal announcement is expected in the coming days. IKS Healthcare, which gave the Jhunjhunwala family a 530-fold return on their investment during its December 2024 listing, is held by three discretionary trusts of the promoter family - Nishtha, Aryavir and Aryaman - with each owning 16.37% of the company. Rekha Jhunjhunwala, Rakesh's widow, owns another 0.23% stake while IKS founder Sachin Gupta holds 33.57%. The promoter group owns a total 63.7% of the company, which seeks to simplify administrative tasks of physicians and medical assistants. The company, founded originally as an RCM service provider in 2006, works with US providers. It manages their tasks as part of the overall care management process. These cover various customer touchpoints, ranging from scheduling to denial management. IKS added transcription service capabilities after its $200 million acquisition of Aquity Solutions in October 2023. This also brought in many client relationships, some of which can be scaled in the medium term. IKS is negotiating for $675 million in financing with Citi, Deutsche Bank and JP Morgan to back its all-cash offer as well as help refinance the target's debt, said the people cited. TruBridge also provides healthcare information technology and services to community hospitals and healthcare organisations.Reported Earnings • Feb 05Third quarter 2026 earnings: EPS in line with expectations, revenues disappointThird quarter 2026 results: EPS: ₹10.96 (up from ₹7.80 in 3Q 2025). Revenue: ₹8.21b (up 25% from 3Q 2025). Net income: ₹1.83b (up 41% from 3Q 2025). Profit margin: 22% (up from 20% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia.공고 • Jan 27Inventurus Knowledge Solutions Limited to Report Q3, 2026 Results on Feb 04, 2026Inventurus Knowledge Solutions Limited announced that they will report Q3, 2026 results on Feb 04, 2026Reported Earnings • Nov 01Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: ₹10.81 (up from ₹6.80 in 2Q 2025). Revenue: ₹7.85b (up 21% from 2Q 2025). Net income: ₹1.81b (up 60% from 2Q 2025). Profit margin: 23% (up from 17% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 8.0%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia.공고 • Oct 15Inventurus Knowledge Solutions Limited to Report First Half, 2026 Results on Oct 30, 2025Inventurus Knowledge Solutions Limited announced that they will report first half, 2026 results on Oct 30, 2025공고 • Sep 26Inventurus Knowledge Solutions Limited Approves Board AppointmentsInventurus Knowledge Solutions Limited at the Annual General Meeting held on September 23, 2025 approved appointment of Dr. Garheng Albert Kong as an Independent Director of the Company; Appointment of Mr. Sachin Gupta as a Director (Non-Executive, Non-Independent) of the Company; Appointment of Ms. Nithya Balasubramanian as the Whole-Time Director of the Company.공고 • Aug 29Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025, at 17:30 Indian Standard Time.Board Change • Aug 15Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Reported Earnings • Aug 02First quarter 2026 earnings released: EPS: ₹9.07 (vs ₹5.75 in 1Q 2025)First quarter 2026 results: EPS: ₹9.07 (up from ₹5.75 in 1Q 2025). Revenue: ₹7.40b (up 16% from 1Q 2025). Net income: ₹1.52b (up 59% from 1Q 2025). Profit margin: 21% (up from 15% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia.공고 • Jul 24Inventurus Knowledge Solutions Limited to Report Q1, 2026 Results on Jul 31, 2025Inventurus Knowledge Solutions Limited announced that they will report Q1, 2026 results on Jul 31, 2025Reported Earnings • May 16Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: ₹29.20 (up from ₹22.37 in FY 2024). Revenue: ₹27.0b (up 49% from FY 2024). Net income: ₹4.86b (up 31% from FY 2024). Profit margin: 18% (down from 20% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia.공고 • Apr 24Inventurus Knowledge Solutions Limited to Report Q4, 2025 Results on May 15, 2025Inventurus Knowledge Solutions Limited announced that they will report Q4, 2025 results on May 15, 2025Valuation Update With 7 Day Price Move • Mar 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹1,447, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 21x in the Healthcare Services industry in Asia. Simply Wall St's valuation model estimates the intrinsic value at ₹768 per share.Reported Earnings • Feb 07Third quarter 2025 earnings releasedThird quarter 2025 results: EPS: ₹7.80. Net income: ₹1.30b (up ₹1.30b from 3Q 2024).Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹1,571, the stock trades at a trailing P/E ratio of 72.2x. Average trailing P/E is 24x in the Healthcare Services industry in Asia.공고 • Jan 17Inventurus Knowledge Solutions Limited to Report Q3, 2025 Results on Feb 05, 2025Inventurus Knowledge Solutions Limited announced that they will report Q3, 2025 results on Feb 05, 2025Board Change • Dec 20Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.이익 및 매출 성장 예측BSE:544309 - 애널리스트 향후 추정치 및 과거 재무 데이터 (INR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/202950,91112,57711,356N/A23/31/202843,47210,26210,425N/A63/31/202737,9798,4717,339N/A66/30/202633,4997,638N/AN/AN/A3/31/202631,9387,2166,1296,736N/A12/31/202530,6016,634N/AN/AN/A9/30/202529,0236,0974,4484,790N/A6/30/202527,6405,421N/AN/AN/A3/31/202526,6404,8612,7553,179N/A12/31/202425,6004,018N/AN/AN/A9/30/202424,6993,7291,9302,493N/A6/30/202421,4263,633N/AN/AN/A3/31/202418,1793,7051,7712,098N/A3/31/202310,3133,0522,7942,880N/A3/31/20227,6362,3302,2222,331N/A3/31/20215,5261,6541,6751,750N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 544309 의 연간 예상 수익 증가율(17.2%)이 saving rate(6.9%)보다 높습니다.수익 vs 시장: 544309 의 연간 수익(17.2%)이 Indian 시장(16.4%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 544309 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 544309 의 수익(연간 14.6%)이 Indian 시장(연간 11%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 544309 의 수익(연간 14.6%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 544309의 자본 수익률은 3년 후 24.9%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/06 11:19종가2026/08/06 00:00수익2026/06/30연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Inventurus Knowledge Solutions Limited는 15명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Soumitra ChatterjeeAvendus SparkVijayaraghavan SwaminathanAvendus Sparknull nullAxis Capital Limited12명의 분석가 더 보기
공고 • 11hInventurus Knowledge Solutions Limited Announces Board ChangesInventurus Knowledge Solutions Limited held its Board of Directors meeting on August 5, 2026, and considered and approved the retirement of Mr. Berjis Desai, Non-Executive Chairman and Non-Independent Director (DIN: 00153675), with effect from the conclusion of the ensuing 20th Annual General Meeting (AGM) on September 21, 2026. The Board has designated Mr. Clarence Carleton King II (DIN: 08171208), Independent Director of the Company, as the Non-Executive Chairman and Independent Director of the Company, with effect from the conclusion of the ensuing 20th AGM September 21, 2026, consequent to the retirement of Mr. Berjis Desai as Non- Executive Chairman and Non-Independent Director. Mr. Berjis Desai has expressed his unwillingness to seek re- appointment at the ensuing 20th Annual General Meeting ("AGM") of the Company, consequent to his appointment at Member of National Commission for Minorities, Government of India, New Delhi. Mr. Clarence Carleton King II (Carl) is a senior health care executive with 40 years of diverse experience. His deep expertise in health care financing and delivery allows Carl to understand the health care system holistically from the perspective of numerous participants. On the delivery side, Carl has run hospitals, clinics and ambulatory surgery centers. On the financing side, he has run HMOs, PPOs and other types of managed care plans. Carl has worked for publicly traded, privately held and provider-sponsored companies. Over the course of his career, he ran local, regional and national organizations with profit and loss responsibility ranging from a few million dollars to over nine billion dollars annually. Carl serves on numerous boards. He is a Certified Corporate Director by the National Association of Corporate Directors and the Indian Institute of Corporate Affairs. Carl also serves as an expert witness in health care cases. He is currently chairing an arbitration panel in a large health care dispute resolution case.
공고 • Jul 28Inventurus Knowledge Solutions Limited to Report Q1, 2027 Results on Aug 05, 2026Inventurus Knowledge Solutions Limited announced that they will report Q1, 2027 results on Aug 05, 2026
Reported Earnings • May 14Full year 2026 earnings: Revenues and EPS in line with analyst expectationsFull year 2026 results: EPS: ₹43.12 (up from ₹29.20 in FY 2025). Revenue: ₹32.1b (up 21% from FY 2025). Net income: ₹7.22b (up 48% from FY 2025). Profit margin: 23% (up from 18% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Healthcare Services industry in Asia.
공고 • May 06Inventurus Knowledge Solutions Limited to Report Q4, 2026 Results on May 13, 2026Inventurus Knowledge Solutions Limited announced that they will report Q4, 2026 results on May 13, 2026
Valuation Update With 7 Day Price Move • Apr 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,654, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Healthcare Services industry in Asia. Total returns to shareholders of 12% over the past year. Simply Wall St's valuation model estimates the intrinsic value at ₹735 per share.
공고 • Apr 17Inventurus Knowledge Solutions Limited Debuts MyCareHub Agentic AI PlatformInventurus Knowledge Solutions Limited announce the groundbreaking launch of MyCareHub™, a proven agentic AI self-orchestrating platform that puts patients first and transforms how they engage with their healthcare journey before, during and after care, at the annual conference of the American Medical Group Association (AMGA) April 15-18. The novel care model, now integrated with Epic and available in the Epic Connection Hub, uses an active, aware and constant multi-agent behavioral algorithm to create a patient engagement operating system that is adaptive, autonomous and patient-first. MyCareHub uses behavioral modeling, longitudinal patient memory, decision intelligence, orchestration logic, safety guardrails and transparent autonomy controls to create a novel patient engagement platform that scores awareness of obligations, ability to meet them and willingness to do so. The channel, cadence and tone of reminders are personalized to drive adherence, ensuring quality care that ultimately lowers total cost of care. IKS Health implemented Recent year-over-year comparison data* from OrthoNY’s MyCareHub platform showed: 4.7% increase in total patient collections; 9.4% increase in patient payments per visit; 8.25% increase in net payments per visit.
공고 • Apr 14Inventurus Knowledge Solutions Reportedly in Advanced Negotiations to Acquire TruBridge for $600 MillionInventurus Knowledge Solutions Limited (NSEI:IKS) is in advanced negotiations to acquire Nasdaq-listed TruBridge, Inc. (NasdaqGS:TBRG) in the US for around $600 million, said people aware of the matter. If the deal takes place, this will be the company's largest purchase and will help consolidate its presence in the healthcare solutions and revenue cycle management (RCM) segment, the people said. The transaction is in line with heightened investor interest in the space, which has seen unprecedented consolidation in the past two years. A formal announcement is expected in the coming days. IKS Healthcare, which gave the Jhunjhunwala family a 530-fold return on their investment during its December 2024 listing, is held by three discretionary trusts of the promoter family - Nishtha, Aryavir and Aryaman - with each owning 16.37% of the company. Rekha Jhunjhunwala, Rakesh's widow, owns another 0.23% stake while IKS founder Sachin Gupta holds 33.57%. The promoter group owns a total 63.7% of the company, which seeks to simplify administrative tasks of physicians and medical assistants. The company, founded originally as an RCM service provider in 2006, works with US providers. It manages their tasks as part of the overall care management process. These cover various customer touchpoints, ranging from scheduling to denial management. IKS added transcription service capabilities after its $200 million acquisition of Aquity Solutions in October 2023. This also brought in many client relationships, some of which can be scaled in the medium term. IKS is negotiating for $675 million in financing with Citi, Deutsche Bank and JP Morgan to back its all-cash offer as well as help refinance the target's debt, said the people cited. TruBridge also provides healthcare information technology and services to community hospitals and healthcare organisations.
Reported Earnings • Feb 05Third quarter 2026 earnings: EPS in line with expectations, revenues disappointThird quarter 2026 results: EPS: ₹10.96 (up from ₹7.80 in 3Q 2025). Revenue: ₹8.21b (up 25% from 3Q 2025). Net income: ₹1.83b (up 41% from 3Q 2025). Profit margin: 22% (up from 20% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia.
공고 • Jan 27Inventurus Knowledge Solutions Limited to Report Q3, 2026 Results on Feb 04, 2026Inventurus Knowledge Solutions Limited announced that they will report Q3, 2026 results on Feb 04, 2026
Reported Earnings • Nov 01Second quarter 2026 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2026 results: EPS: ₹10.81 (up from ₹6.80 in 2Q 2025). Revenue: ₹7.85b (up 21% from 2Q 2025). Net income: ₹1.81b (up 60% from 2Q 2025). Profit margin: 23% (up from 17% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 8.0%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia.
공고 • Oct 15Inventurus Knowledge Solutions Limited to Report First Half, 2026 Results on Oct 30, 2025Inventurus Knowledge Solutions Limited announced that they will report first half, 2026 results on Oct 30, 2025
공고 • Sep 26Inventurus Knowledge Solutions Limited Approves Board AppointmentsInventurus Knowledge Solutions Limited at the Annual General Meeting held on September 23, 2025 approved appointment of Dr. Garheng Albert Kong as an Independent Director of the Company; Appointment of Mr. Sachin Gupta as a Director (Non-Executive, Non-Independent) of the Company; Appointment of Ms. Nithya Balasubramanian as the Whole-Time Director of the Company.
공고 • Aug 29Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025Inventurus Knowledge Solutions Limited, Annual General Meeting, Sep 23, 2025, at 17:30 Indian Standard Time.
Board Change • Aug 15Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Reported Earnings • Aug 02First quarter 2026 earnings released: EPS: ₹9.07 (vs ₹5.75 in 1Q 2025)First quarter 2026 results: EPS: ₹9.07 (up from ₹5.75 in 1Q 2025). Revenue: ₹7.40b (up 16% from 1Q 2025). Net income: ₹1.52b (up 59% from 1Q 2025). Profit margin: 21% (up from 15% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia.
공고 • Jul 24Inventurus Knowledge Solutions Limited to Report Q1, 2026 Results on Jul 31, 2025Inventurus Knowledge Solutions Limited announced that they will report Q1, 2026 results on Jul 31, 2025
Reported Earnings • May 16Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: ₹29.20 (up from ₹22.37 in FY 2024). Revenue: ₹27.0b (up 49% from FY 2024). Net income: ₹4.86b (up 31% from FY 2024). Profit margin: 18% (down from 20% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia.
공고 • Apr 24Inventurus Knowledge Solutions Limited to Report Q4, 2025 Results on May 15, 2025Inventurus Knowledge Solutions Limited announced that they will report Q4, 2025 results on May 15, 2025
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹1,447, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 21x in the Healthcare Services industry in Asia. Simply Wall St's valuation model estimates the intrinsic value at ₹768 per share.
Reported Earnings • Feb 07Third quarter 2025 earnings releasedThird quarter 2025 results: EPS: ₹7.80. Net income: ₹1.30b (up ₹1.30b from 3Q 2024).
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹1,571, the stock trades at a trailing P/E ratio of 72.2x. Average trailing P/E is 24x in the Healthcare Services industry in Asia.
공고 • Jan 17Inventurus Knowledge Solutions Limited to Report Q3, 2025 Results on Feb 05, 2025Inventurus Knowledge Solutions Limited announced that they will report Q3, 2025 results on Feb 05, 2025
Board Change • Dec 20Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Theresa Stone was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.